Your browser doesn't support javascript.
loading
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Enomoto, Noriyuki; Homma, Sakae; Inase, Naohiko; Kondoh, Yasuhiro; Saraya, Takeshi; Takizawa, Hajime; Inoue, Yoshikazu; Ishii, Hiroshi; Taguchi, Yoshio; Izumi, Shinyu; Yamano, Yasuhiko; Tanino, Yoshinori; Nishioka, Yasuhiko; Toyoshima, Mikio; Yokomura, Koshi; Imokawa, Shiro; Koshimizu, Naoki; Sano, Takehisa; Akamatsu, Taisuke; Mukae, Hiroshi; Kato, Motoyasu; Hamada, Naoki; Chiba, Hirofumi; Akagawa, Shinobu; Muro, Shigeo; Uruga, Hironori; Matsuda, Hiroyuki; Kaida, Yusuke; Kanai, Miho; Mori, Kazutaka; Masuda, Masafumi; Hozumi, Hironao; Fujisawa, Tomoyuki; Nakamura, Yutaro; Ogawa, Noriyoshi; Suda, Takafumi.
Afiliação
  • Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan norieno@hama-med.ac.jp.
  • Homma S; Department of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, Tokyo, Japan.
  • Inase N; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan.
  • Saraya T; Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Takizawa H; Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
  • Ishii H; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Taguchi Y; Department of Respiratory Medicine, Tenri Hospital, Nara, Japan.
  • Izumi S; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan.
  • Tanino Y; Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
  • Nishioka Y; Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Toyoshima M; Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan.
  • Yokomura K; Department of Respiratory Medicine, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
  • Imokawa S; Department of Respiratory Medicine, Iwata City Hospital, Iwata, Japan.
  • Koshimizu N; Department of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
  • Sano T; Department of Respiratory Medicine, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
  • Akamatsu T; Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kato M; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Hamada N; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Chiba H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Akagawa S; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
  • Muro S; Department of Respiratory Medicine, Nara Medical University, Nara, Japan.
  • Uruga H; Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
  • Matsuda H; Department of Respiratory Medicine, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
  • Kaida Y; Department of Respiratory Medicine, Enshu Hospital, Hamamatsu, Japan.
  • Kanai M; Respiratory and Allergy Medicine, National Hospital Organization Tenryu Hospital, Hamamatsu, Japan.
  • Mori K; Respiratory Medicine, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
  • Masuda M; Respiratory Medicine, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
  • Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Nakamura Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Ogawa N; Division of Immunology and Rheumatology, Department of Internal Medicine 3, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Thorax ; 77(2): 143-153, 2022 02.
Article em En | MEDLINE | ID: mdl-34272335
BACKGROUND: Some patients with idiopathic interstitial pneumonia (IIP) show autoimmune features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a research concept in these patients. However, retrospective studies reported conflicting results of its prognosis. Therefore, this study was conducted to prospectively evaluate the clinical significance of autoimmune features in patients with IIP. METHODS: This nationwide multicentre study prospectively enrolled consecutive patients with IIP. At the diagnosis, we systematically evaluated 63 features suggestive of connective tissue diseases using a checklist including symptoms/signs and autoantibodies, which contained most items of the IPAF criteria and followed up with the patients. Clinical phenotypes were included in a cluster analysis. RESULTS: In 376 patients with IIP enrolled, 70 patients (18.6%) met the IPAF criteria. The proportion of patients with IPAF was significantly lower in idiopathic pulmonary fibrosis (IPF) than in non-IPF (6.0% vs 24.3%, respectively). During a median observation period of 35 months, patients with IPAF more frequently developed systemic autoimmune diseases and had less frequent acute exacerbation of IIPs than patients with non-IPAF. IPAF diagnosis was significantly associated with better survival and was an independent positive prognostic factor in total and patients with non-IPF. Cluster analysis by similarity of clinical phenotypes identified a cluster in which there was a higher number of women, and patients had more autoimmune features and a better prognosis than other clusters. INTERPRETATION: These observations suggest that some patients with IIP show autoimmune features with distinct characteristics and favourable prognosis. However, we were not able to determine the appropriate therapies for these patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Pneumonias Intersticiais Idiopáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Pneumonias Intersticiais Idiopáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article